Pancreatic Cancer Research

ResearcherCapital Medical UniversityNo recent work listed

Ang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7403-2705; OpenAlex author ID A5100413623. Sources: OpenAlex.

Their work

Papers
12 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
35
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 4 papers · 2021: 2 papers · 2022: 1 paper

Papers 12

  1. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/pcmedi/pbac010↗
  2. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.cca.2021.03.020↗
  3. The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12967-021-02972-6↗
  4. Laparoscopic advanced intraoperative restaging for radiographic non-metastasis pancreatic cancer: Protocol for a single-center, cross-sectional and follow-up s… First author DOI 10.1097/md.0000000000022090↗
  5. Alteration of Transforming Growth Factor β Signaling Pathway Predicts Worse Prognosis in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1097/mpa.0000000000001522↗
  6. The Germline/somatic DNA Damage Repair Gene Mutations Modulate the Therapeutic Response in Chinese Patients With Advanced Pancreatic Ductal Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-60530/v1↗
  7. Oral microbiome and pancreatic cancer. Co-author DOI 10.3748/wjg.v26.i48.7679↗
  8. Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer. First author DOI 10.2217/fon-2017-0339↗
  9. Radical antegrade modular pancreatosplenectomy versus standard procedure in the treatment of left-sided pancreatic cancer: A systemic review and meta-analysis. Co-author DOI 10.1186/s12893-017-0259-1↗
  10. Prognostic significance of positive peritoneal cytology in resectable pancreatic cancer: a systemic review and meta-analysis. Co-author DOI 10.18632/oncotarget.14745↗
  11. dCK Expression and Gene Polymorphism With Gemcitabine Chemosensitivity in Patients With Pancreatic Ductal Adenocarcinoma: A Strobe-Compliant Observational Stud… Co-author DOI 10.1097/md.0000000000002936↗
  12. Fascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomes. Co-author DOI 10.1053/j.gastro.2014.01.046↗

Closest collaborators

The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Li Mao · 4 shared papers, 2020–2021 · strength 0.43
  2. Fei Li · 3 shared papers, 2017–2020 · strength 0.36
  3. Yanfang Jiang · 2 shared papers, 2021–2022 · strength 0.36
  4. Dan Cao · 2 shared papers, 2020–2021 · strength 0.23
  5. Lin Shui · 2 shared papers, 2020–2021 · strength 0.22
  6. Bole Tian · 2 shared papers, 2020–2021 · strength 0.22
  7. Feng Cao · 2 shared papers, 2017 · strength 0.20
  8. Bicheng Ye · 1 shared paper, 2022 · strength 0.19
  9. Xubao Liu · 2 shared papers, 2016–2020 · strength 0.17
  10. Zhi Zheng · 1 shared paper, 2020 · strength 0.16
  11. Shuangshuang Li · 1 shared paper, 2021 · strength 0.12
  12. Heli Gao · 1 shared paper, 2021 · strength 0.12
  13. Yi Cheng · 1 shared paper, 2021 · strength 0.12
  14. Ning An · 1 shared paper, 2021 · strength 0.12
  15. Yu Mou · 1 shared paper, 2020 · strength 0.11
  16. Bole Tian · 1 shared paper, 2020 · strength 0.11
  17. Dan Cao · 1 shared paper, 2020 · strength 0.11
  18. Jue Yuan · 1 shared paper, 2020 · strength 0.10
  19. Hongying Liu · 1 shared paper, 2020 · strength 0.10
  20. Ailin Wei · 1 shared paper, 2020 · strength 0.10
  21. Zhenlu Li · 1 shared paper, 2020 · strength 0.10
  22. Mei Rosemary Fu · 1 shared paper, 2020 · strength 0.10
  23. Jiaxin Liu · 1 shared paper, 2018 · strength 0.09
  24. Hou‐Qun Ying · 1 shared paper, 2018 · strength 0.09
  25. Junjie Xiong · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.